secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001558370-24-004285
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health reports Q4 net loss of $31.6M on $69.7M revenue; FY 2023 revenue up 13%
--------------------------------------------------------------------------------

- Q4 revenue $69.7M (+30% YoY); net loss $31.6M including $29.1M non-cash asset impairment.
- FY 2023 revenue $247.6M (+13% YoY); net loss $45.8M vs $424.8M in 2022.
- Adjusted EBITDA Q4 $3.1M (vs -$5.9M); FY $10.8M (vs $12.6M).
- Hospital division operating income $36.3M (+142%); net cash from operating activities $1.3M.
- Management initiated 2024 strategic plan for cost reduction and portfolio optimization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/0001558370-24-004285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/nutx-20240328x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-004285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer